3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
64
INDUSTRY
8
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
3
Thoracic
2
Head & Neck
2
Gastrointestinal
2
Other hematologic neoplasm
1
Gynecologic
1
Genitourinary
1
Endocrine
1
Breast
1
Conditions
Ovarian Neoplasms
1
Fallopian Tube Neoplasms
1
Cystadenocarcinoma, Serous
1
Interventions
Cisplatin
9
apatinib
5
Surgical Procedures, Operative
4
Radiotherapy
4
Paclitaxel
4
Hyperthermic Intraperitoneal Chemotherapy
4
Hydralazine
4
Gemcitabine
4
Carboplatin
4
Valproic Acid
3
Neoadjuvant Therapy
3
Drug Therapy
3
Bevacizumab
3
taxane
2
pembrolizumab
2
cetrorelix
2
Radiotherapy, Intensity-Modulated
2
Probiotics
2
Population Groups
2
Poly(ADP-ribose) Polymerase Inhibitors
2
Metformin
2
Laparoscopy
2
Indocyanine Green
2
Etoposide
2
Curcumin
2
CP protocol
2
Brachytherapy
2
spartalizumab
1
piperine
1
olaparib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Blood Specimen Collection
×
Gynecologic
×
Clear all
NCT03150121
2020-02-26
BEDOCA
Sheba Medical Center
Phase NA
Unknown
500 enrolled